Molecular Devices Rank: 85 (2005 rank: N/A) Get quote:MDCC
CEO: Joseph D. Keegan, Ph.D. Headquarters: Sunnyvale, CA Employees: 543
ANALYSIS
Molecular Devices develops systems that speed drug development and other life-sciences research. Scientists use them to analyze thousands of samples in a day.
In our sixth annual list, we once again asked financial research firm Zacks to rank public companies with revenues of less than $200 million and a stock price of more than $1, based on their three-year growth in earnings, revenue, and performance. (Banks and real-estate firms were excluded, they overrun the list.)
How we pick the 25 richest executives
Equilar, an executive-compensation research firm in San Mateo, Calif., reviewed proxy statements for firms on the FSB 100 list. When the shares owned outright and vested options are factored in, these 25 executives have the most bling. In fact, each has $19 million or more in stock and options.
